community download

Presentation: Pneumococcal Conjugate Vaccine for Adults: A New Paradigm

information we require

please check before submitting



Unfortunately the document is not available at this current time, however if you leave your details we'll get it to you as soon as we can.

Please fill in all the information requested. It is very important you enter this information correctly so we can contact you with the document.

Privacy statement »

Manage your email preferences »

Remember my details Information

Information
Remember my details
We place a 'cookie' on your computer so next time you visit us you don't need to fill in all these details

In April 2013 over 500 delegates participated in the 13th Annual World Vaccine Congress Washington. This event brings together vaccine leaders and policy makers from around the globe. Attendees at this highly successful event were fortunate enough to hear this exciting presentation delivered by William Gruber, Pfizer entitled: ‘Pneumococcal Conjugate Vaccine for Adults: A New Paradigm’

This presentation outlines:

  • Efficacy of PPSV23
  • Limitations of Polysaccharide Vaccine
  • Free Polysaccharide Vaccine Immunobiology T-Cell Independent Response
  • Advantages of Polysaccharide Conjugate Vaccine
  • Polysaccharide Conjugate Vaccine Immunobiology T-Cell Dependent Response
  • Conjugate Vaccine Efficacy Against Pneumococcal Disease in Children
  • Efficacy of PCV7 and PPSV23 in HIV Infected Adults
  • Goals of the PCV13 Adult Phase 3 Program
  • Functional Antibody is Targeted Against Capsule Polysaccharide (CPS)
  • Measure of Anti-Pneumococcal Immunity
  • Direct Comparison of Responses to PCV13 and PPSV23